Nick Turner
Professor Nick Turner is a prominent medical oncologist and lead researcher at the Institute of Cancer Research and The Royal Marsden. He has played a crucial role in the development of innovative cancer therapies, including the newly approved drug capivasertib, which has shown promising results in slowing the progression of advanced breast cancer. His research focuses on improving treatment options and outcomes for patients, emphasizing the importance of effective and kinder therapies in the management of cancer.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 9.00 | 0.04% | +0% | 67,886,011 | 28,476 | $2,700,000 | 1,133$ |
| Totals | 1 | 67,886,011 | 28,476 | $2,700,000 | 1,133$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Nick Turner is a professor of molecular oncology at the Institute of Cancer Research, London, and consultant medical oncologist at the Royal Marsden NHS Foundation Trust.
9
United Kingdom:
Prof Nick Turner is the lead researcher and professor of medical oncology at the Institute of Cancer Research and The Royal Marsden.
8